7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
      
    		                
      cash flows from operating activities
    		                
      net income
    		2,793,000 -37,603,000 15,438,000 10,583,000 27,495,000 -36,800,000 679,000 -17,893,000 -2,761,000 -67,431,000 18,244,000 32,240,000 124,381,000 97,505,000 165,786,000 118,881,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                
      depreciation and amortization
    		4,741,000 4,800,000 4,929,000 4,997,000 4,509,000 5,437,000 4,873,000 5,276,000 5,118,000 1,093,000 713,000 703,000 887,000 633,000 651,000 699,000 
      amortization of financing costs and debt discount and premium
    		274,000 273,000 273,000 274,000 471,000 510,000 812,000 329,000 362,000 208,000 257,000 301,000 172,000 131,000 131,000  
      share-based compensation
    		10,005,000 11,250,000 12,313,000 10,624,000 12,732,000 11,810,000 9,694,000 10,655,000 11,119,000 9,360,000 8,702,000 9,624,000 6,552,000 7,266,000 3,591,000 2,452,000 
      equity in income of investments
    		2,251,000 7,510,000 -371,000 3,177,000 3,488,000 5,188,000 6,903,000 1,877,000 2,470,000 -464,000 1,253,000 1,596,000 -3,840,000 -997,000 -983,000 -2,103,000 
      changes in unrealized loss on general partner notes payable
    		-75,000 -92,000               
      non-cash lease amortization
    		-149,000 -145,000 -46,000 189,000 174,000 229,000 138,000 -73,000         
      reserve for credit losses
    		4,820,000 1,358,000 3,212,000 648,000 52,000 295,000           
      unrealized performance allocations
    		-1,466,000 12,410,000 -93,000 -612,000 -18,532,000 61,670,000 -4,519,000 50,940,000 19,284,000 107,025,000 4,436,000 16,367,000 -70,116,000 -65,862,000   
      unrealized accrued performance allocations compensation
    		404,000 1,090,000 1,272,000 760,000 -1,151,000 3,178,000 6,961,000 1,788,000 -4,649,000 -14,670,000 3,856,000 3,789,000 7,987,000 9,238,000   
      change in deferred income taxes
    		-90,000 822,000 1,083,000 -2,621,000 98,000 -22,000 4,672,000 -390,000 262,000 29,000 13,183,000 -249,000     
      other non-cash adjustments
    		  59,000 232,000             
      changes in operating assets and liabilities:
    		                
      receivable from affiliates
    		-5,192,000 20,356,000 -10,679,000 -2,958,000 1,587,000 -2,238,000 -4,053,000 -6,845,000 19,451,000 -7,350,000 -908,000 -18,710,000 21,842,000 -19,873,000 -1,711,000  
      prepaid and other assets
    		3,837,000 -1,840,000 13,697,000 -17,616,000 3,853,000 -13,622,000 5,418,000 -11,850,000 3,805,000 -7,962,000 8,886,000 -8,466,000 -1,432,000 2,140,000   
      accounts payable and accrued expenses
    		781,000 -4,055,000 13,721,000 -8,338,000 -4,629,000 3,422,000 10,803,000 1,536,000 273,000 -2,452,000 -5,710,000 5,240,000 -1,867,000 13,320,000 4,918,000  
      accrued payroll and benefits
    		14,871,000 -33,168,000 17,323,000 -2,439,000 14,596,000 -11,694,000 14,527,000 -4,057,000 10,536,000 -1,957,000 -2,454,000 -10,558,000 7,627,000 5,921,000 1,113,000 -6,018,000 
      other liabilities
    		-4,887,000 -1,087,000 -4,121,000 7,924,000 -4,475,000 -2,351,000 -2,761,000 7,224,000 -1,867,000 -2,681,000 -434,000 7,559,000 -1,017,000 323,000 -1,883,000  
      insurance loss and self-insurance reserves
    		-6,090,000 9,173,000 2,481,000 2,158,000 1,626,000 2,238,000 2,431,000 1,531,000 -2,282,000 1,022,000 -1,794,000 2,637,000 -1,010,000 1,475,000 1,825,000  
      accrued performance allocations compensation
    		  52,000 -11,000 0 -2,037,000 -791,000 0   146,000 276,000 1,002,000 -560,000 -1,006,000 -7,051,000 
      net cash from operating activities
    		27,006,000 -8,948,000 70,428,000 6,734,000 42,954,000 25,089,000 63,648,000 38,489,000 59,861,000 12,815,000 45,911,000 40,063,000 91,990,000 50,389,000 56,363,000 54,384,000 
      cash flows from investing activities
    		                
      purchase of investments
    		-6,623,000 -2,355,000 -7,146,000 -4,921,000 -10,492,000 -6,743,000 -13,520,000 -24,234,000 -24,802,000 -5,909,000 -8,417,000 -39,543,000 -18,111,000 -17,273,000 -3,429,000 -7,950,000 
      proceeds from sale of investments
    		  0 0 0 17,206,000 0         1,193,000 
      distributions from investments
    		328,000 890,000     0 1,350,000 34,000 6,000 1,000 521,000 -292,000 1,147,000   
      sale of marketable securities
    		10,841,000 2,000 5,049,000 6,830,000 6,206,000 3,000 1,718,000 5,000 2,553,000 1,867,000 0      
      issuance of notes receivable
    		-7,388,000 -9,905,000 -28,866,000 -87,333,000 -77,562,000 -116,402,000 -37,494,000 -73,237,000 -74,853,000 -60,186,000 -95,047,000 -134,445,000 -173,925,000 -68,980,000 -198,143,000 -239,125,000 
      proceeds from collections on notes receivable
    		7,879,000 3,455,000 25,750,000 86,689,000 79,588,000 119,762,000 43,393,000 78,093,000 75,254,000 67,998,000 97,581,000 132,932,000 128,163,000 190,092,000 103,475,000  
      purchase of tenant improvements, furniture and equipment
    		-42,000 -38,000 6,000 -33,000 16,000 -113,000 -416,000 -359,000 -1,225,000 -408,000 -2,602,000 162,000 -593,000 -195,000 -228,000  
      net cash from investing activities
    		4,995,000 -7,951,000 -2,027,000 1,232,000 -2,244,000 13,713,000 -6,319,000 2,144,000 -23,039,000 -315,996,000 -9,297,000 -38,191,000 -50,349,000 75,954,000 -128,360,000 -19,094,000 
      cash flows from financing activities
    		                
      capital contributions from non-controlling interests
    		  -1,946,000 718,000 10,987,000 4,995,000 1,032,000 12,616,000 4,218,000 11,000 0 12,000 31,000 170,000   
      distributions to non-controlling interests
    		-9,903,000 -18,643,000 -22,332,000 -18,654,000 -25,292,000 -16,844,000 -27,122,000 -38,011,000 -43,288,000 -25,428,000 -35,968,000 -50,837,000 -80,792,000 -46,081,000 -31,848,000  
      repayments of general partner notes payable
    		-157,000 -235,000     0 -1,363,000   -9,000 -539,000 -357,000 -103,000 -241,000 -460,000 
      dividends paid on class a common stock
    		0 -4,889,000 -4,188,000 -5,440,000 -5,309,000 -2,582,000 -5,733,000 -5,805,000 -4,850,000 -5,541,000 -7,831,000 -8,861,000 -7,613,000 -5,918,000   
      proceeds from revolving line of credit
    		0 27,500,000 10,000,000 115,700,000 86,250,000 123,000,000 36,000,000 150,000,000 100,000,000 150,000,000 0 0     
      payments on revolving line of credit
    		-14,500,000 -13,000,000 -21,700,000 -111,000,000 -94,750,000 -141,500,000 -52,000,000 -180,000,000 -100,000,000 -70,000,000 0 0     
      payments of deferred financing costs
    		  0 0 0 -821,000 0 -261,000 -255,000 -1,669,000 0 -1,366,000     
      net cash from financing activities
    		-24,213,000 -9,267,000 -40,166,000 -18,676,000 -28,114,000 -33,752,000 -47,823,000 -62,824,000 -44,334,000 197,373,000 -43,808,000 88,409,000 -89,746,000 -51,932,000 -37,919,000 91,341,000 
      net increase in cash, cash equivalents, and restricted cash
    		7,788,000 -26,166,000 28,235,000 -10,710,000 12,596,000 5,050,000 9,506,000 -22,191,000 -7,512,000 -105,808,000 -7,194,000 90,281,000 -48,105,000 74,411,000 -109,916,000  
      cash, cash equivalents and restricted cash - beginning of period
    		0 102,431,000  0 0 67,260,000 0 0 0 193,265,000 0 0 0 83,872,000   
      cash, cash equivalents and restricted cash - end of period
    		7,788,000 76,265,000  -10,710,000 12,596,000 72,310,000 9,506,000 -22,191,000 -7,512,000 87,457,000 -7,194,000 90,281,000 -48,105,000 158,283,000   
      changes in unrealized gain on general partner notes payable
    		    -98,000 -124,000 -810,000 -1,559,000 -443,000 -943,000 -1,144,000 -2,040,000 993,000 -171,000  -415,000 
      due to affiliates
    		      0 0         
      deposits
    		          -813,000 882,000 14,409,000 -13,748,000   
      cash paid for acquisition, net of cash acquired
    		      0 0 0 -319,364,000 0 0 0 -15,089,000   
      borrowings on private notes
    		      0 0 0 150,000,000 0      
      cash, cash equivalents and restricted cash — beginning of period
    		                
      cash, cash equivalents and restricted cash — end of period
    		                
      distributions to members
    		              0 -18,377,000 
      proceeds from issuance of common stock—ipo, net of underwriting discount and issuance costs
    		                
      purchase of membership interests in operating company
    		              0  
      proceeds from issuance of common stock—underwriters' exercise of over-allotment option, net of underwriting discount and issuance costs
    		                
      repurchase of membership interests
    		              0 1,000 
      amortization of lease liabilities
    		         -12,000 -75,000 -246,000 -108,000 -100,000 -73,000  
      loss on disposal of furniture and equipment
    		                
      repayments of notes payable
    		                
      proceeds from issuance of common stock —underwriters' exercise of over-allotment option, net of underwriting discount and issuance costs
    		                
      supplemental disclosure of cash flow information:
    		                
      cash paid for income taxes
    		            1,448,000 618,000   
      cash paid for interest
    		            77,000 3,041,000 -98,000 5,047,000 
      non-cash investing and financing activities:
    		                
      establishment of lease liabilities in exchange for lease right-of-use assets
    		            2,984,000 15,824,000   
      origination of short-term loan receivable for prepaid acquisitions
    		            0 40,000,000   
      deferred tax effect resulting from exchange of class a units under tax receivable agreement
    		            782,000 5,166,000   
      issuance of class a units for acquisition
    		            0 14,930,000   
      non-controlling interest assumed in business combination
    		            0 20,053,000   
      reconciliation of cash, cash equivalents and restricted cash:
    		                
      cash and cash equivalents
    		            -46,344,000 149,121,000 -109,921,000 126,790,000 
      restricted cash
    		            -1,761,000 9,162,000 5,000 -159,000 
      cash, cash equivalents, and restricted cash
    		            -48,105,000 158,283,000 -109,916,000 126,631,000 
      changes in unrealized (gain) loss on general partner notes payable
    		                
      deposits on acquisitions
    		                
      proceeds from issuance of common stock - ipo, net of underwriting discount and issuance costs
    		              0  
      proceeds from issuance of common stock - underwritersʼ exercise of over-allotment option, net of underwriting discount and issuance costs
    		              0  
      borrowings from private notes
    		                
      borrowings from notes payable
    		                
      repayment of notes payable
    		                
      proceeds from line of credit
    		              50,000,000 21,000,000 
      repayments on line of credit
    		                
      cash, cash equivalents and restricted cash - beginning of year
    		                
      cash, cash equivalents and restricted cash - end of year
    		                
      net cash paid for income taxes
    		              467,000  
      settlement of accrued performance allocations compensation liability with equity
    		              0  
      derecognition of bridge debt strategies fund gp llc
    		              0  
      changes in unrealized performance allocations
    		               -53,042,000 
      changes in unrealized accrued performance allocations compensation
    		                
      prepaid and other current assets
    		               -1,545,000 
      capital contributions
    		               186,000 
      payments of line of credit
    		               -21,000,000 
      fund management fees
    		                
      funds
    		                
      joint ventures and separately managed accounts
    		                
      total fund management fees
    		                
      cash flows from operating activities:
    		                
      amortization of deferred financing costs and debt discount and premium
    		                
      amortization of lease incentives
    		                
      receivables from affiliates
    		                
      other assets
    		                
      account payable and accrued expenses
    		                
      other current liabilities
    		                
      insurance loss reserves
    		                
      self-insurance reserves and unearned premiums
    		                
      deferred rent
    		                
      cash flows from investing activities:
    		                
      proceeds from repayment of notes receivable
    		                
      purchase of tenant improvements and office equipment
    		                
      cash flows from financing activities:
    		                
      distributions to non-controlling interest
    		                
      net decrease in cash, cash equivalents, and restricted cash
    		                
      cash, cash equivalents and restricted cash – beginning of period
    		                
      cash, cash equivalents and restricted cash – end of period
    		                
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.